title: Vanadate, but not insulin, inhibits insulin receptor gene expression in rat hepatoma cells.
abstract: Insulin and vanadate treatments have recently been shown to reverse the overexpression of the hepatic insulin receptor (IR) gene in streptozotocin-induced diabetic rats. To better understand the mechanisms underlying these effects, the abilities of insulin and vanadate to affect IR gene expression have been comparatively examined in Fao hepatoma cells, an insulin-responsive cell line. Exposure of Fao cells to insulin (1 microM) or vanadate (500 microM) for 24 h led to a 2-fold decrease in IR number in total cellular membranes. Insulin treatment did not affect IR messenger RNA (mRNA) level regardless of time of exposure and concentration. In contrast, vanadate treatment caused a time- and dose-dependent decrease in IR mRNA level, which was maximal (4-fold change) after a 24-h exposure to 500 microM vanadate and was fully reversible. Insulin treatment increased from 28 to 39% the relative expression of isotype A IR mRNA, but vanadate treatment did not significantly affect this parameter. Vanadate treatment did not modify mRNA half-life (3.5 h) in 5, 6 dichlorobenzimidazole riboside-treated cells but decreased by 4-fold the transcriptional activity of the IR gene. These data show for the first time that, although both insulin and vanadate decrease total cellular IR number in Fao cells, only vanadate decreases IR mRNA level. It does so by inhibiting transcription of the IR gene, suggesting an action on the gene promoter which could be mediated by changes in the level of expression and/or of phosphorylation of trans-acting factors.
authors.affiliation: Unité 30 INSERM, Hôpital Necker-Enfants Malades, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Bortoli
authors.forename: M
authors.initials: M
authors.lastname: Amessou
authors.forename: M
authors.initials: M
authors.lastname: Collinet
authors.forename: B
authors.initials: B
authors.lastname: Desbuquois
authors.forename: S
authors.initials: S
authors.lastname: Lopez
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000235:genetics* / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004355:Drug Stability; D015870:Gene Expression / Q000187:drug effects*; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology; D007536:Isomerism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011972:Receptor, Insulin / Q000235:genetics* / Q000378:metabolism; D013997:Time Factors; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014638:Vanadates / Q000494:pharmacology*
chemical_list: D007328:Insulin; D012333:RNA, Messenger; D014638:Vanadates; D011972:Receptor, Insulin